Ocugen (OCGN) Non-Current Deferred Tax Liability (2014)

Ocugen (OCGN) posted Non-Current Deferred Tax Liability of $651000.0 for Q4 2014.

Ocugen (OCGN) Non-Current Deferred Tax Liability (2014) Analysis & Trends

Ocugen's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $651000.0 for Q4 2014.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $651000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $651000.0 (changed N/A YoY) and the FY2014 annual result came in at $651000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was $651000.0 for Q4 2014 at Ocugen.
Across five years, Non-Current Deferred Tax Liability topped out at $651000.0 in Q4 2014 and bottomed at $651000.0 in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ocugen	63.79 Mn	63.79 Mn	-

Download Data

Date	Value
Dec 31, 2014	651,000.00
Dec 31, 2014	651,000.00